Found: 3
Select item for more details and to access through your institution.
Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size.
- Published in:
- Journal of Oncology Pharmacy Practice, 2009, v. 15, n. 4, p. 201, doi. 10.1177/1078155208101960
- By:
- Publication type:
- Article
No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response, or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 4, p. 772, doi. 10.1002/cncr.23607
- By:
- Publication type:
- Article
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time-point does matter?
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 856, doi. 10.1002/ajh.21850
- By:
- Publication type:
- Article